← All stocks

Jazz Pharmaceuticals plc

JAZZ Net selling
CIK 0001232524 #749 in the set updated 17 Sep 2026
Bought (12 mo)
$0.00
out of their own pocket, the only kind of buying there is
Sold (12 mo)
$68.72M
$12.91M on a plan · $48.96M straight out of an exercise
Sold at will
$6.85M
11 of 59 sales
Net
−$68.72M
−$6.85M against sales at will

By person

20 insiders · 60 transactions
34.4×

Renee D. Gala holds 34.4 times base salary in stock. $34.55M of shares against $1.00M in salary for 2025.

Salary from the company's own proxy. The shares are what Renee D. Gala last reported holding, valued at $240.94, the price Ordinary Shares was last bought or sold at on the open market here, on 10 Sep 2026.

Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
COZADD BRUCE C
Director
$27.15M (21) scheduled
−$27.15M
351,875
0.5421%
$84.78M
−17.6%
Iannone Robert
EVP, Global Head of R&D & CMO
$20.41M (7) scheduled
−$20.41M
65,686
0.1012%
$15.83M
+4.8%
Patil Neena M
EVP & Chief Legal Officer
$11.50M (14) scheduled
−$11.50M
47,671
0.0734%
$11.49M
+28.1%
Carr Patricia
SVP, Chief Accounting Officer
$2.46M (7) scheduled
−$2.46M
6,512
0.0100%
$1.57M
−5.3%
Winningham Rick E
Director
$1.66M (2)
−$1.66M
9,466
0.0146%
$2.28M
−25.4%
Pearce Samantha
EVP, Chief Commercial Officer
$1.63M (1) scheduled
−$1.63M
47,131
0.0726%
$11.36M
+90.7%
Henderson Mary Elizabeth
SVP, Technical Operations
$1.42M (2)
−$1.42M
23,815
0.0367%
$5.74M
+63.9%
McSharry Heather Ann
Director
$1.09M (2) scheduled
−$1.09M
18,199
0.0280%
$4.38M
−3.7%
RIEDEL NORBERT G
Director
$655.68K (1) scheduled
−$655.68K
17,553
0.0270%
$4.23M
+10.0%
GALA RENEE D
President & CEO
$486.06K (1) scheduled
−$486.06K
143,394
0.2209%
$34.55M
+156.2%
Smith Mark Douglas
Director
$266.75K (1) scheduled
−$266.75K
9,579
0.0148%
$2.31M
+4.9%
Mulligan Seamus
Director
1,286,254
1.98%
$309.91M
+9.4%
Johnson Philip L
EVP & Chief Financial Officer
56,431
0.0869%
$13.60M
+97.5%
O'Keefe Kenneth W
Director
25,811
0.0398%
$6.22M
+4.4%
ENRIGHT PATRICK G
Director
21,278
0.0328%
$5.13M
−13.8%
ORiordan Anne
Director
16,500
0.0254%
$3.98M
+11.5%
Cook Jennifer E.
Director
10,736
0.0165%
$2.59M
+17.5%
Hamill Laura
Director
6,832
0.0105%
$1.65M
+30.6%
Kennedy Patrick
Director
6,452
0.0099%
$1.55M
+25.2%
LOVE TED W
Director
2,389
0.0037%
$575.61K
Insider
Date
Role
Action
Shares
Price
Amount
Iannone Robert
27 Aug 2026
EVP, Global Head of R&D & CMO
Sold after exercise
300
$252.76
$75.83K
Iannone Robert
27 Aug 2026
EVP, Global Head of R&D & CMO
Sold after exercise
9,259
$251.95
$2.33M
Iannone Robert
27 Aug 2026
EVP, Global Head of R&D & CMO
Sold after exercise
19,639
$250.60
$4.92M
Iannone Robert
27 Aug 2026
EVP, Global Head of R&D & CMO
Sold after exercise
18,113
$250.02
$4.53M
Iannone Robert
27 Aug 2026
EVP, Global Head of R&D & CMO
Sold after exercise
11,423
$248.67
$2.84M
Iannone Robert
27 Aug 2026
EVP, Global Head of R&D & CMO
Sold after exercise
18,187
$247.86
$4.51M
Pearce Samantha
28 May 2026
EVP, Chief Commercial Officer
Sold after exercise
6,907
$235.41
$1.63M
Winningham Rick E
22 May 2026
Director
Sold after exercise
2,741
$241.57
$662.14K
RIEDEL NORBERT G
27 Feb 2026
Director
Sold after exercise
3,415
$192.00
$655.68K
Patil Neena M
26 Feb 2026
EVP & Chief Legal Officer
Sold after exercise
197
$193.60
$38.14K
Patil Neena M
26 Feb 2026
EVP & Chief Legal Officer
Sold after exercise
1,009
$192.79
$194.53K
Patil Neena M
26 Feb 2026
EVP & Chief Legal Officer
Sold after exercise
1,784
$191.88
$342.31K
Patil Neena M
26 Feb 2026
EVP & Chief Legal Officer
Sold after exercise
549
$190.80
$104.75K
Patil Neena M
26 Feb 2026
EVP & Chief Legal Officer
Sold after exercise
1,061
$190.00
$201.59K
Patil Neena M
26 Feb 2026
EVP & Chief Legal Officer
Sold after exercise
3,523
$193.58
$681.99K
Patil Neena M
26 Feb 2026
EVP & Chief Legal Officer
Sold after exercise
11,529
$191.65
$2.21M
Patil Neena M
26 Feb 2026
EVP & Chief Legal Officer
Sold after exercise
2,916
$189.81
$553.49K
Patil Neena M
26 Feb 2026
EVP & Chief Legal Officer
Sold after exercise
15,555
$190.28
$2.96M
Patil Neena M
26 Feb 2026
EVP & Chief Legal Officer
Sold after exercise
875
$192.07
$168.06K
Patil Neena M
26 Feb 2026
EVP & Chief Legal Officer
Sold after exercise
16,602
$192.53
$3.20M
Carr Patricia
5 Dec 2025
SVP, Chief Accounting Officer
Sold after exercise
4,500
$171.20
$770.41K
Carr Patricia
5 Dec 2025
SVP, Chief Accounting Officer
Sold after exercise
160
$171.11
$27.38K
COZADD BRUCE C
26 Nov 2025
Director
Sold after exercise
38,126
$177.27
$6.76M
COZADD BRUCE C
26 Nov 2025
Director
Sold after exercise
507
$179.79
$91.15K
COZADD BRUCE C
26 Nov 2025
Director
Sold after exercise
8,380
$179.23
$1.50M
COZADD BRUCE C
26 Nov 2025
Director
Sold after exercise
30,487
$178.06
$5.43M
McSharry Heather Ann
20 Nov 2025
Director
Sold after exercise
3,415
$177.78
$607.13K
Carr Patricia
18 Nov 2025
SVP, Chief Accounting Officer
Sold after exercise
5,250
$182.07
$955.87K
Carr Patricia
18 Nov 2025
SVP, Chief Accounting Officer
Sold after exercise
69
$181.66
$12.53K

What was left out

Form 4 filings counted 84
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 19
Sales straight out of an exercise 29
Sales at will 11
Transactions with no price 0
Shares from compensation/vesting 536,121
History held since 20 Sep 2016